Michael Greiner - 03 Jan 2023 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP - Chief Financial Officer
Signature
/s/ Mojirade James, as attorney-in-fact for Michael C. Greiner
Issuer symbol
AVNS
Transactions as of
03 Jan 2023
Net transactions value
-$127,886
Form type
4
Filing time
04 Jan 2023, 14:55:52 UTC
Previous filing
08 Mar 2022
Next filing
23 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Tax liability $127,886 -4,726 -4.8% $27.06 93,765 03 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on January 2, 2020 with a 3-year cliff vesting period.